The Sperm Count Test market is estimated to be valued at US$ 517.5 million in 2023 and is expected to exhibit a CAGR of 12.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A sperm count test, also known as a semen analysis, measures the concentration of sperm in a man’s ejaculate to assess his fertility potential. It determines sperm count, mobility, shape, volume, and pH to evaluate the health of sperm and detect possible fertility issues. The test is typically the first step in evaluating male fertility concerns and is useful for men who wish to father children, experience difficulty conceiving, or have undergone treatments that may affect sperm production.
The global sperm count test market is expected to grow exponentially over the forecast period, driven by rising rates of male infertility around the world and increasing demand for assisted reproductive technologies like IVF. Nearly one in seven couples experience infertility issues to some degree, with male factors accounting for over 50% of cases. The rising prevalence of lifestyle conditions like obesity, stress, and genital infections that negatively impact sperm health is driving more men to undergo fertility testing. Furthermore, the surging number of IVF procedures performed globally is anticipated to fuel demand for sperm count tests to assess male fertility prior to assisted reproduction treatments. Advancements in rapid, home-based sperm testing kits are also expected to support market growth by improving accessibility and convenience.
The global Sperm Count Test market is dominated by the At-Home sperm count testing kits sub-segment. This sub-segment accounts for over 60% share of the market owing to the convenience and privacy it offers to patients compared to clinical laboratory tests. At-Home kits allow patients to test sperm count from the comfort of their homes and avoid waiting times at clinics or hospitals.
Political: Favourable government initiatives to spread awareness about male infertility issues and providing access to advanced fertility treatments are boosting market growth.
Economic: Rising disposable incomes and improved healthcare spending are driving higher adoption of sperm count testing kits across regions.
Social: Increasing social acceptance of male infertility issues and growing societal focus on early treatment seeking behaviour are supporting market revenues.
Technological: Advancements in concept of self-testing kits, miniaturization of diagnostic equipment, integration of AI and digitization are expanding capabilities and access to sperm count testing.
The global Sperm Count Test Market Trend is expected to witness high growth, exhibiting CAGR of 12.5% over the forecast period, due to rising male infertility rates worldwide. The market size is projected to reach US$ 1.1 Billion by 2030 from US$ 517.5 million in 2023.
North America holds the largest share of the global Sperm Count Test market and is expected to maintain its lead through 2030. This can be attributed to advanced healthcare infrastructure, rising awareness levels, favourable reimbursement policies and presence of leading market players in the region.
Key players operating in the Sperm Count Test market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home Health. Key players are focusing on new product launches, enhancing geographical presence and mergers & acquisitions to strengthen their market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it